308 Federal Register / Vol. 89, No. 2 / Wednesday, January 3, 2024 / Proposed Rules 

1 88 FR 74379 (Oct. 31, 2023). 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

21 CFR Part 1301 

[Docket No. DEA–1144] 

RIN 1117–AB84 

Controlled Substance Destruction 

Alternatives to Incineration; Extension 

of Comment Period 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: Advance notice of proposed 

rulemaking; extension of comment 

period. 

SUMMARY: The Drug Enforcement 

Administration (DEA) published an 

advance notice of proposed rulemaking 

entitled ‘‘Controlled Substance 

Destruction Alternatives to 

Incineration’’ in the Federal Register on 

October 31, 2023. DEA is extending the 

comment period on that advance notice 

until April 1, 2024. 

DATES: The comment period for the 

advanced notice of proposed 

rulemaking published October 31, 2023, 

at 88 FR 74379 is extended until April 

1, 2024. Electronic comments must be 

submitted, and written comments must 

be postmarked, on or before April 1, 

2024. Commenters should be aware that 

the electronic Federal Docket 

Management System will not accept 

comments after 11:59 p.m. Eastern Time 

on the last day of the comment period. 

ADDRESSES: To ensure proper handling 

of comments, please reference ‘‘RIN 

1117–AB84/Docket No. DEA–1144’’ on 

all correspondence, including any 

attachments. 

• Electronic comments: DEA 

encourages that all comments be 

submitted electronically through the 

Federal eRulemaking Portal, which 

provides the ability to type comments 

directly into the comment field on the 

web page or to attach a file containing 

comments. Please go to http://

www.regulations.gov and follow the 

online instructions at that site for 

submitting comments. Upon completion 

of your submission, you will receive a 

Comment Tracking Number for your 

comment generated by http://

www.regulations.gov. Please be aware 

that submitted comments are not 

instantaneously available for public 

view on http://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted, and there is no 

need to resubmit the same comment. 

• Paper comments: Paper comments 

that duplicate the electronic submission 

are discouraged. Should you wish to 

mail a paper comment in lieu of 

submitting a comment electronically, it 

should be sent via regular or express 

mail to: Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. Hand-delivered comments will 

not be accepted. 

FOR FURTHER INFORMATION CONTACT: 

Scott A. Brinks, Regulatory Drafting and 

Policy Support Section, Diversion 

Control Division, Drug Enforcement 

Administration; Telephone: (571) 776– 

3882. 

SUPPLEMENTARY INFORMATION: 

Posting of Public Comments 

Please note that all comments 

received in response to this docket are 

considered part of the public record. 

The Drug Enforcement Administration 

(DEA) will make all comments available 

for public inspection online at http://

www.regulations.gov. Such information 

includes personal or business identifiers 

(such as name, address, state or Federal 

identifiers, etc.) voluntarily submitted 

by the commenter. All information 

voluntarily submitted by the 

commenter, unless clearly marked as 

Confidential Information in the method 

described below, will be publicly 

posted. Comments may be submitted 

anonymously. The Freedom of 

Information Act applies to all comments 

received. 

Commenters submitting comments 

which include personal identifying 

information (PII), confidential, or 

proprietary business information that 

the commenter does not want made 

publicly available should submit two 

copies of the comment. One copy must 

be marked ‘‘CONTAINS 

CONFIDENTIAL INFORMATION’’ and 

should clearly identify all PII or 

business information the commenter 

does not want to be made publicly 

available, including any supplemental 

materials. DEA will review this copy, 

including the claimed PII and 

confidential business information, in its 

consideration of comments. The second 

copy should be marked ‘‘TO BE 

PUBLICLY POSTED’’ and must have all 

claimed confidential PII and business 

information already redacted. DEA will 

post only the redacted comment on 

http://www.regulations.gov for public 

inspection. 

For easy reference, an electronic copy 

of this document and a plain language 

summary are available at http://

www.regulations.gov. 

Summary 

On October 31, 2023, DEA published 

an advance notice of proposed 

rulemaking (ANPRM) requesting 

stakeholder responses to ten questions 

about methods and technology currently 

being utilized or developed to render 

controlled substances non-retrievable.1

Since publication, DEA received two 

requests from stakeholders for an 

extension of the comment period due to 

timeliness difficulties preparing 

adequate comments to the ANPRM 

during the holidays. One of those 

commenters, an association, stated that 

its member companies have a significant 

interest in this ANPRM, and requested 

an extension to allow them to provide 

timely and informative comments. 

After considering these requests for 

additional response time, DEA is 

extending the comment period to allow 

stakeholders to prepare and submit 

comments. This allows sufficient time 

for persons to evaluate and consider all 

relevant information and respond 

accordingly. Therefore, the comment 

period is extended to April 1, 2024. 

Electronic comments must be 

submitted, and written comments must 

be postmarked, on or before this date. 

Signing Authority 

This document of the Drug 

Enforcement Administration was signed 

on December 28, 2023, by Administrator 

Anne Milgram. That document with the 

original signature and date is 

maintained by DEA. For administrative 

purposes only, and in compliance with 

requirements of the Office of the Federal 

Register, the undersigned DEA Federal 

Register Liaison Officer has been 

authorized to sign and submit the 

document in electronic format for 

publication, as an official document of 

DEA. This administrative process in no 

way alters the legal effect of this 

document upon publication in the 

Federal Register. 

Scott Brinks, 

Federal Register Liaison Officer, Drug 

Enforcement Administration. 

[FR Doc. 2023–28964 Filed 12–29–23; 11:15 am] 

BILLING CODE 4410–09–P 


ddrumheller on DSK120RN23PROD with PROPOSALS1